ArticleVascular specialist international2025
Conservative Management of Massive Retroperitoneal Hemorrhage in a Patient with Vascular Ehlers-Danlos Syndrome: A Case Report.
Article in Vascular specialist international, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Retroperitoneal hemorrhage in patients with vascular Ehlers-Danlos syndrome (vEDS) is uncommon, and its optimal management remains controversial because both surgical and endovascular interventions carry substantial risks. A 36-year-old man with vEDS presented with persistent upper abdominal pain. Computed tomography (CT) revealed a massive retroperitoneal hematoma, approximately 20 cm in size, with a pseudoaneurysm in a mesenteric artery branch but without contrast extravasation. Considering the potential complications associated with the intervention and the patient's overall stable hemodynamic condition, a conservative management approach under careful supervision was selected. A follow-up CT revealed a reduction in hematoma size, and the patient was discharged after 19 days of hospitalization without complications. Conservative management of retroperitoneal hemorrhage in patients with vEDS may be considered a viable option in hemodynamically stable conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.